Trial Outcomes & Findings for Investigations of Ear Tip Performance, Perceptions, and Experiences (NCT NCT05725824)

NCT ID: NCT05725824

Last Updated: 2024-07-29

Results Overview

Evaluation of ear canal acoustics with participant wearing a hearing aid and earmold type (3d party control, in-house\_Resin, in-house\_PLA). Then, a thin microphone tube is placed in the ear canal to measure the average amount gain (dB SPL) across various frequencies (250-8000Hz) while the participant sits in front of a speaker playing sound samples. Results are recorded in gain (dB SPL) across frequencies. Once complete, the earmold type is changed and recording is repeated until all ear mold material types have been tested for each individual. Arms/Groups were collapsed for RM-ANOVA to compare between various earmold types. A post-hoc paired t-test w/ Bonferroni correction was utilized to compare ear mold material types.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

15 minutes

Results posted on

2024-07-29

Participant Flow

Participant milestones

Participant milestones
Measure
3rd Party Control, Then In-house PLA, Then In-house_RES
In this arm, participants were first fit and tested with a 3rd party control, then in-house PLA, then in-house\_RES earmold
In-house_RES, Then 3rd Party Control, Then In-house PLA
In this arm, participants were first fit and tested with a in-house\_RES, then 3rd party control, then a in-house\_PLA earmold
In-house PLA, Then In-house_RES, Then 3rd Party Control
In this arm, participants were fit with a in-house PLA, then in-house\_RES, then 3rd party control earmold.
Overall Study
STARTED
10
10
10
Overall Study
COMPLETED
10
10
10
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Investigations of Ear Tip Performance, Perceptions, and Experiences

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall Group
n=30 Participants
Crossover trial of 30 individuals with normal hearing
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
24 Participants
n=5 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
1 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
2 Participants
n=5 Participants
Race/Ethnicity, Customized
Black or African American
2 Participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic/Latino
7 Participants
n=5 Participants
Race/Ethnicity, Customized
White/Non-hispanic
14 Participants
n=5 Participants
Race/Ethnicity, Customized
More than one race
4 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 15 minutes

Evaluation of ear canal acoustics with participant wearing a hearing aid and earmold type (3d party control, in-house\_Resin, in-house\_PLA). Then, a thin microphone tube is placed in the ear canal to measure the average amount gain (dB SPL) across various frequencies (250-8000Hz) while the participant sits in front of a speaker playing sound samples. Results are recorded in gain (dB SPL) across frequencies. Once complete, the earmold type is changed and recording is repeated until all ear mold material types have been tested for each individual. Arms/Groups were collapsed for RM-ANOVA to compare between various earmold types. A post-hoc paired t-test w/ Bonferroni correction was utilized to compare ear mold material types.

Outcome measures

Outcome measures
Measure
3rd Party Control
n=30 Participants
Participants each wore and were tested with 3rd party control ear mold for 15 minutes.
In-house_RES
n=30 Participants
Participants each wore and were tested with study in-house\_RES ear mold for 15 minutes.
In-house_PLA
n=30 Participants
Participants each wore and were tested with study in-house\_PLA ear mold for 15 minutes.
Real Ear Measures
REAG_2000s
61.23 dB SPL
Standard Deviation 2.49
60.23 dB SPL
Standard Deviation 2.01
60.5 dB SPL
Standard Deviation 2.27
Real Ear Measures
REAG_1000m
64.53 dB SPL
Standard Deviation 2.61
66.5 dB SPL
Standard Deviation 2.73
66.23 dB SPL
Standard Deviation 2.65
Real Ear Measures
REAG_500l
74.43 dB SPL
Standard Deviation 2.01
75.4 dB SPL
Standard Deviation 2.11
74.5 dB SPL
Standard Deviation 2.00
Real Ear Measures
REAG_1000l
70.83 dB SPL
Standard Deviation 2.57
72.23 dB SPL
Standard Deviation 3.17
71.8 dB SPL
Standard Deviation 3.40

PRIMARY outcome

Timeframe: 2nd listening session appointment (15 minutes)

A questionnaire eliciting patient perception of physical comfort, quality of voice, and overall self-perceived satisfaction. Includes 12 items (5 point) that are scored on a 0 to 100, with 100 representing best possible function/rating

Outcome measures

Outcome measures
Measure
3rd Party Control
n=30 Participants
Participants each wore and were tested with 3rd party control ear mold for 15 minutes.
In-house_RES
n=30 Participants
Participants each wore and were tested with study in-house\_RES ear mold for 15 minutes.
In-house_PLA
n=30 Participants
Participants each wore and were tested with study in-house\_PLA ear mold for 15 minutes.
Outer Effectiveness of Auditory Rehabilitation (EAR) Questionnaire
PerceptVoice
3.6 score on a scale
Standard Deviation 0.97
3.77 score on a scale
Standard Deviation 1.22
3.6 score on a scale
Standard Deviation 1.22
Outer Effectiveness of Auditory Rehabilitation (EAR) Questionnaire
NaturalSound
3.17 score on a scale
Standard Deviation 1.02
3.43 score on a scale
Standard Deviation 1.25
3.3 score on a scale
Standard Deviation 1.12
Outer Effectiveness of Auditory Rehabilitation (EAR) Questionnaire
PhysComfort
3.9 score on a scale
Standard Deviation 0.97
4 score on a scale
Standard Deviation 1.11
3.73 score on a scale
Standard Deviation 1.05

PRIMARY outcome

Timeframe: Prior to 2nd listening session appointment (15 minutes)

Physical dimensions of each ear mold type (3rd party Control, in-house\_Resin, in-house\_PLA) were taken using digital calipers in millimeters prior to being worn by participants.

Outcome measures

Outcome measures
Measure
3rd Party Control
n=30 Participants
Participants each wore and were tested with 3rd party control ear mold for 15 minutes.
In-house_RES
n=30 Participants
Participants each wore and were tested with study in-house\_RES ear mold for 15 minutes.
In-house_PLA
n=30 Participants
Participants each wore and were tested with study in-house\_PLA ear mold for 15 minutes.
Physical Dimensions
HeightTotal
27.19 millimeters
Standard Deviation 2.01
27.73 millimeters
Standard Deviation 1.92
27.39 millimeters
Standard Deviation 1.85
Physical Dimensions
WidthTotal
21.42 millimeters
Standard Deviation 3.76
22.50 millimeters
Standard Deviation 3.55
22.23 millimeters
Standard Deviation 3.49
Physical Dimensions
VentDiam
2.56 millimeters
Standard Deviation 0.41
2.51 millimeters
Standard Deviation 0.37
2.23 millimeters
Standard Deviation 0.36
Physical Dimensions
DepthTotal
15.25 millimeters
Standard Deviation 1.66
13.88 millimeters
Standard Deviation 2.26
13.65 millimeters
Standard Deviation 1.86
Physical Dimensions
Height_mEC
7.72 millimeters
Standard Deviation 1.13
8.21 millimeters
Standard Deviation 0.91
8.38 millimeters
Standard Deviation 0.99

PRIMARY outcome

Timeframe: Prior to 2nd listening session appointment (15 minutes)

The total raw cost ($) for each ear mold type (3rd party\_control, in-house\_RES, and in-house\_PLA).

Outcome measures

Outcome measures
Measure
3rd Party Control
n=30 Participants
Participants each wore and were tested with 3rd party control ear mold for 15 minutes.
In-house_RES
n=30 Participants
Participants each wore and were tested with study in-house\_RES ear mold for 15 minutes.
In-house_PLA
n=30 Participants
Participants each wore and were tested with study in-house\_PLA ear mold for 15 minutes.
Production Variable
59.95 dollars ($)
Standard Deviation 0.00
1.29 dollars ($)
Standard Deviation 0.20
0.04 dollars ($)
Standard Deviation 0.00

Adverse Events

3rd Party Control, Then In-house_PLA, Then In-house_Resin

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

In-house_Resin, Then 3rd Party Control, Then In-house_PLA

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

In-house_PLA, Then In-house_Resin, Then 3rd Party Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Bryan Wong

University of Arizona

Phone: 5206268549

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place